skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pharma Intelligence Logo
Search Icon Pharma Report StoreRecommendationsProduct loginProductLogin
Global Search Configuration

​Go behind the headlines

Scrip Industry News and Insights

With exclusive access to key industry decision makers and best-in-class proprietary data, Scrip empowers you to understand the news behind the news.

How it helps

Use Scrip’s focus on the strategic implications of global pharma news to fully understand what worldwide developments in the industry mean for your business.

With end-to-end coverage encompassing the whole of the drug discovery, development, and product life cycle value chain, Scrip delivers analysis, news and insights across multiple therapy areas and product types.

How it works

Scrip provides business-critical market and company intelligence from our global network of analysts, journalists and key opinion leaders. They cover companies across the industry, from biotech start-ups to multinational giants such as Pfizer, Sanofi and Shire, and report on fields including cardiovascular, diabetes, dermatology, influenza, and oncology.

Scrip gives you access to the latest licensing opportunities, partnership deals, R&D activity, market access insights and company developments. Your subscription also includes the Scrip 100 annual review, which tracks and analyzes the performance of over 600 companies and provides additional insights into pharma industry topics that impact your business. 

Start a free trial

What's included

Follow market developments

Follow market developments

Scrips global team of journalists span key markets around the clock

Go beyond headlines

Go beyond the news

Get exclusive access to accurate data, timely insights and trusted analysis that delivers to gain competitive advantage

 

 

 
Hear from newsmakers

Hear from news makers

Access interviews with leading decision makers, industry experts and thought leaders, across the industry.

 
ask the expert

Ask the expert

Put your questions about any of our news stories, data and analysis to our expert journalists and analysts.

 

Pharma Intelligence: latest

Meet the team

Editor

Brenda Sandburg

Editor, Senior Editor

New York

Brenda Sandburg

Brenda specializes in

  • Policy & Regulation
  • Biosimilars
  • Biotech
  • Generics
  • Pricing & Reimbursement

+38 year(s) experience

Profile
Editor

Cathy Kelly

Editor, Senior editor

Washington DC

Cathy Kelly

Cathy specializes in

  • Policy & Regulation
  • Market Intelligence
  • Market Access
  • Pricing & Reimbursement

+38 year(s) experience

Profile
Management

Denise Peterson

Management, Editor In Chief, Pharma US

Washington DC

Denise Peterson

Denise specializes in

  • Commercial Strategy
  • Policy & Regulation

+37 year(s) experience

Profile
See all analysts

How we've helped other businesses

"Scrip helps me to stay current with pharmaceutical news on a world-wide basis."

​Wendy Johnson ​CEO, Aires Pharmaceuticals, USA

"RxScorecard™ provides a comprehensive, multi-pronged rubric assisting us in decision-making as we begin to move from a volume to value drug evaluation methodology."

​Chronis H. Manolis, RPh ​Vice President, Pharmacy UPMC Health Plan

"RxScorecard™ lets a biopharma company anticipate the most important factors impacting the clinical & economic value of pipeline and marketed drugs -- and then helps identify the necessary changes to the clinical development and commercial program to maximize that value for all stakeholders, especially including payers. It's a required, straightforward, objective strategic tool that allows us to quickly and effectively adapt to a rapidly changing and much more challenging market access environment."

​Ammar Qadan ​Global Value/Market Access Lead Oncology Portfolio & Global Commercial Lead Oncology Biomarkers Halozyme Therapeutics, Inc.

Keep up to date

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Start a free trial

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.
General enquiry

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now